Join Erich Bozenhardt as he presents his poster, "Biosafety for Viral Gene Therapies," at the ISPE 2020 Biopharmaceutical Manufacturing Virtual Conference throughout both days.

With a maturing pipeline of Gene Therapies, companies are developing commercial manufacturing spaces at a rapid rate.

The novel processes/organisms are challenging companies to develop a look at their Biosafety operational practices, how those practices and GMP compliance influence the design of facilities. This poster will help build an understanding of how to classify vectors/cell lines, how risk groups translate into facility design, and what GMP practices around containment need to be considered for viral gene therapies.

The ISPE 2020 Biopharmaceutical Manufacturing Virtual Conference will focus on innovation in facilities, production methods, and technologies that enable a competitive and sustainable biopharmaceutical product supply for the future. This conference will bring together experts that are developing, implementing, and operating advanced supply chains providing high-quality medicines to global markets.

Read more and register here: https://ispe.org/conferences/2020-ispe-biopharmaceutical-manufacturing-virtual-conference/agenda